As Parliament looms, a new battle over Canada's Access to Medicines Regime is ignited.
With less than five weeks to go before Parliament resumes, players from pharmaceutical giants to grandmothers are already lobbying hard on a new bill that would make it easier for generic drug manufacturers to produce name-brand medicine for developing countries.